{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:01:08Z","timestamp":1774645268747,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.4158\/ep-2020-0132","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T21:27:35Z","timestamp":1592947655000},"page":"1093-1104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients"],"prefix":"10.1016","volume":"26","author":[{"given":"An","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2020-0132_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"suppl 2","key":"10.4158\/EP-2020-0132_bb0015","first-page":"N37","article-title":"Hyperparathyroidism in hereditary syndromes: special expressions and special managements","volume":"17","author":"Marx","year":"2002","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP-2020-0132_bb0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J Intern Med."},{"key":"10.4158\/EP-2020-0132_bb0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","article-title":"Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism","volume":"3","author":"Starker","year":"2012","journal-title":"Horm Cancer."},{"key":"10.4158\/EP-2020-0132_bb0030","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1210\/jc.2010-1338","article-title":"Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas","volume":"96","author":"Costa-Guda","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0132_bb0035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI200113180","article-title":"Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB","volume":"108","author":"Ding","year":"2001","journal-title":"J Clin Invest."},{"key":"10.4158\/EP-2020-0132_bb0040","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1210\/jc.2004-2450","article-title":"GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone","volume":"90","author":"Thomee","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0132_bb0045","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1210\/jc.2007-2167","article-title":"Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism","volume":"93","author":"Mannstadt","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0132_bb0050","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/jc.2007-1783","article-title":"Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study","volume":"93","author":"Maret","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0132_bb0055","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet."},{"key":"10.4158\/EP-2020-0132_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.surg.2017.04.027","article-title":"Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure","volume":"163","author":"El","year":"2018","journal-title":"Surgery."},{"key":"10.4158\/EP-2020-0132_bb0065","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1210\/jc.2018-02517","article-title":"Analysis of activating GCM2 sequence variants in sporadic parathyroid adenomas","volume":"104","author":"Riccardi","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0132_bb0070","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg."},{"key":"10.4158\/EP-2020-0132_bb0075","doi-asserted-by":"crossref","first-page":"e0166634","DOI":"10.1371\/journal.pone.0166634","article-title":"Clinical and genetic analysis of multiple endocrine neoplasia type 1-related primary hyperparathyroidism in Chinese","volume":"11","author":"Kong","year":"2016","journal-title":"PLoS One."},{"key":"10.4158\/EP-2020-0132_bb0080","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/cen.13453","article-title":"Primary hyperparathyroidism in Chinese children and adolescents: a single-centre experience at Peking Union Medical College Hospital","volume":"87","author":"Wang","year":"2017","journal-title":"Clin Endocrinol."},{"key":"10.4158\/EP-2020-0132_bb0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40618-019-01107-5","article-title":"Whole exome sequencing in familial isolated primary hyperparathyroidism","volume":"43","author":"Cetani","year":"2020","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP-2020-0132_bb0090","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/jbmr.3854","article-title":"Genetic screening in a large Chinese cohort of childhood onset hypoparathyroidism by next-generation sequencing combined withTBX1 -MLPA","volume":"34","author":"Wang","year":"2019","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP-2020-0132_bb0095","author":"NCBI","year":"2020"},{"key":"10.4158\/EP-2020-0132_bb0100","author":"EMBL-EBI","year":"2020"},{"key":"10.4158\/EP-2020-0132_bb0105","author":"Exome Variant Server","year":"2020"},{"key":"10.4158\/EP-2020-0132_bb0110","author":"GnomAD Browser","year":"2020"},{"key":"10.4158\/EP-2020-0132_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"10.4158\/EP-2020-0132_bb0120","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1073\/pnas.94.9.4739","article-title":"The regulator of early gliogenesis glial cells missing is a transcription factor with a novel type of DNA-binding domain","volume":"94","author":"Schreiber","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.4158\/EP-2020-0132_bb0125","doi-asserted-by":"crossref","first-page":"E2794","DOI":"10.1210\/jc.2014-2857","article-title":"Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts","volume":"99","author":"D\u2019Agruma","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0132_bb0130","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1074\/jbc.275.7.4774","article-title":"Protein stability and domain topology determine the transcriptional activity of the mammalian glial cells missing homolog, GCMb","volume":"275","author":"Tuerk","year":"2000","journal-title":"J Biol Chem."},{"key":"10.4158\/EP-2020-0132_bb0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1530\/EJE-19-0641","article-title":"Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?","volume":"182","author":"Coppin","year":"2020","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP-2020-0132_bb0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/JOE-10-0247","article-title":"Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism","volume":"210","author":"Mannstadt","year":"2011","journal-title":"J Endocrinol."},{"key":"10.4158\/EP-2020-0132_bb0145","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/js.2017-00043","article-title":"Ethnicity of patients with germline GCM2-activating variants and primary hyperparathyroidism","volume":"1","author":"Guan","year":"2017","journal-title":"J Endocr Soc."},{"key":"10.4158\/EP-2020-0132_bb0150","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.biopha.2017.05.028","article-title":"Specifying the molecular pattern of sporadic parathyroid tumorigenesis-The Y282D variant of the GCM2 gene","volume":"92","author":"Marchiori","year":"2017","journal-title":"Biomed Pharmacother."},{"key":"10.4158\/EP-2020-0132_bb0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/cen.12461","article-title":"Familial isolated primary hyperparathyroidism\/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese","volume":"81","author":"Kong","year":"2014","journal-title":"Clin Endocrinol."},{"key":"10.4158\/EP-2020-0132_bb0160","author":"UniProt","year":"2020"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20482163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20482163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:09:36Z","timestamp":1761516576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20482163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1530891X20482163"],"URL":"https:\/\/doi.org\/10.4158\/ep-2020-0132","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2020-0132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}